Oral Agents and SARS-CoV-2 Vaccine Effectiveness against Severe COVID-19 Omicron Events in Patients Requiring Maintenance Dialysis

Kidney360. 2024 Mar 1;5(3):445-450. doi: 10.34067/KID.0000000000000373. Epub 2024 Feb 1.

Authors

Harold J Manley¹, Nien Chen Li¹, Caroline M Hsu², Daniel E Weiner², Dana Miskulin², Antonia M Harford¹, Doug Johnson¹, Eduardo Lacson Jr^{1

2}

Affiliations

¹ Dialysis Clinic Inc., Nashville, Tennessee.
² Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.

No abstract available

MeSH terms

Administration, Oral
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
Renal Dialysis
SARS-CoV-2
Vaccine Efficacy

Substances

COVID-19 Vaccines